Europe

Italy and France have announced their readiness to resume vaccination of AstraZeneca

The authorities of Italy and announced their readiness to resume the use of the coronavirus vaccine, which was created by the British-Swedish company AstraZeneca, in the vaccination campaigns of their countries. This is reported on the website of the Italian government.

Italian Prime Minister Mario Draghi held a telephone conversation with French President Emmanuel Macron. They discussed the suspension of the AstraZeneca drug in some European countries. “This is a temporary precautionary measure that will last until Thursday, March 18, until the analysis of the European Medicines Agency (EMA) is completed,” the report said.

If the EMA gives a positive verdict on the drug, Italy, and are ready to “immediately return to its use”.

20 European countries have decided to ban the use of the AstraZeneca vaccine. The authorities of Austria, Bulgaria, Cyprus, Denmark, Estonia, France, Germany, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, the Netherlands, Norway, Portugal, Romania, Slovenia, and have partially or completely stopped vaccination. The cause was the occurrence of thrombosis in the vaccinated.

At the same time, the company stated about the safety of the vaccine. AstraZeneca explained that a detailed study of the health status of more than 17 million people vaccinated in the EU and the UK with the coronavirus drug showed no data on an increased risk of pulmonary embolism, deep vein thrombosis, or thrombocytopenia.



Leave a Reply